Biomedical Frontiers, Inc.

Address

1095 Tenth Avenue, S.E.
Minneapolis, MN, 55413

Information

DUNS:
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. MACROMOLECULAR CONTRAST AGENTS FOR MAGNETIC RESONANCE

    Amount: $675,000.00

    BIOMEDICAL FRONTIERS (BMF) HAS ESTABLISHED THAT THE IRON CHELATOR, DEFEROXAMINE, CAN BE COVALENTLY BOUND TO POLYMERS AND HAS DEMONSTRATED, IN PRECLINICAL STUDIES, THAT THESE CONJUGATES CAN BE USED THE ...

    SBIRPhase II1994Department of Health and Human Services
  2. Tumor Growth Inhibition by Iron Deprivation

    Amount: $80,250.00

    This research will determine the potential utility of novel high molecular weight iron chelatorsas anti-cancer agents or adjuncts to other iron-depriving therapeutic strategies in the treatment ofcanc ...

    SBIRPhase I1994Department of Health and Human Services
  3. MACROMOLECULAR CONTRAST AGENTS FOR MAGNETIC RESONANCE

    Amount: $50,000.00

    N/A

    SBIRPhase I1991Department of Health and Human Services
  4. SYNTHESIS OF HIGH MOLECULAR WEIGHT IRON CHELATORS

    Amount: $249,000.00

    IN CHEMICAL AND BIOLOGICAL SYSTEMS, IRON IS BOTH UBIQUITOUS AND HIGHLY REACTIVE. IN A VARIETY OF CIRCUMSTANCES, THERE IS GREAT NEED FOR NEW APPROACHES TO THE REMOVAL OF IRON OR THE CONTROL OF ITS REAC ...

    SBIRPhase II1987Department of Health and Human Services
  5. SYNTHESIS OF HIGH MOLECULAR WEIGHT IRON CHELATORS

    Amount: $44,000.00

    N/A

    SBIRPhase I1986Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government